PP
PTCT icon

PDT Partners’s PTC Therapeutics PTCT Stock Holding History

PDT Partners’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-25,684
Closed -$1.25M – 701
2025
Q2 		$1.25M Sell
25,684
-14,651
-36% -$696K 0.07% 381
2025
Q1 		$2.06M Sell
40,335
-51,746
-56% -$2.58M 0.15% 244
2024
Q4 		$4.16M Sell
92,081
-72,987
-44% -$3.12M 0.37% 67
2024
Q3 		$6.12M Buy
165,068
+25,688
+18% +$860K 0.54% 12
2024
Q2 		$4.26M Sell
139,380
-35,859
-20% -$1.16M 0.4% 49
2024
Q1 		$5.1M Sell
175,239
-268
-0.2% -$7.51K 0.48% 30
2023
Q4 		$4.84M Buy
175,507
+111,112
+173% +$2.54M 0.53% 29
2023
Q3 		$1.44M Buy
64,395
+1,478
+2% +$55K 0.18% 186
2023
Q2 		$2.56M Sell
62,917
-47
-0.1% -$2.3K 0.35% 75
2023
Q1 		$3.05M Buy
62,964
+69
+0.1% +$3.15K 0.41% 74
2022
Q4 		$2.4M Sell
62,895
-7,684
-11% -$319K 0.39% 58
2022
Q3 		$3.54M Sell
70,579
-26,452
-27% -$1.3M 0.54% 7
2022
Q2 		$3.89M Buy
97,031
+3,062
+3% +$107K 0.34% 47
2022
Q1 		$3.51M Buy
+93,969
New +$3.62M 0.3% 73
2019
Q1 		– Sell
-277,609
Closed -$9.53M – 488
2018
Q4 		$9.53M Sell
277,609
-12
-0% -$431 0.53% 48
2018
Q3 		$13M Buy
277,621
+20
+0% +$828 0.54% 48
2018
Q2 		$9.36M Buy
277,601
+1
+0% +$31 0.36% 98
2018
Q1 		$7.51M Buy
+277,600
New +$7.03M 0.25% 134
2017
Q1 		– Sell
-161,100
Closed -$1.76M – 522
2016
Q4 		$1.76M Sell
161,100
-5,000
-3% -$52.5K 0.12% 261
2016
Q3 		$2.33M Buy
+166,100
New +$1.35M 0.14% 205

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PDT Partners's PTCT Position: Q3 2025 in Review

PDT Partners sold out of PTC Therapeutics (PTCT) in Q3 2025, closing a stake of 25,684 shares — an estimated $1.25M sold.

PDT Partners first reported a position in PTCT in Q3 2016 and held it in 20 quarters. The position peaked at $13M in Q3 2018. 294 funds tracked by Wall St. Rank hold PTCT as of Q3 2025.

  • PDT Partners reported no remaining PTC Therapeutics position as of Q3 2025 after selling out during the quarter.
  • PDT Partners sold 25,684 PTC Therapeutics shares in Q3 2025, an estimated $1.25M.
  • PDT Partners first reported a position in PTC Therapeutics in Q3 2016 and held it in 20 quarters.
  • PDT Partners's PTC Therapeutics position peaked at $13M in Q3 2018.
  • 294 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2025.

Based on PDT Partners's 13F filing for Q3 2025, filed 17 Nov 2025.